Fig. 4From: A physiologically based pharmacokinetic (PBPK) model to describe organ distribution of 68Ga-DOTATATE in patients without neuroendocrine tumorsPredicted 68Ga-DOTATATE concentration–time curves (solid lines) for spleen (a), liver (b) and thyroid (c). Ranges (dashed lines) are based on minima and maxima of administered peptide amounts (8.05 and 16.9 µg) and SSTR2 densityBack to article page